Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The purpose of these experiments was to investigate a potential role for vascular endothelial growth factor (VEGF) in mediating vascular dysfunction induced by increased glucose flux via the sorbitol pathway. Skin chambers were mounted on the backs of Sprague-Dawley rats and 1 wk later, granulation tissue in the chamber was exposed twice daily for 7 d to 5 mM glucose, 30 mM glucose, or 1 mM sorbitol in the presence and absence of neutralizing VEGF antibodies. Albumin permeation and blood flow were increased two- to three-fold by 30 mM glucose and 1 mM sorbitol; these increases were prevented by coadministration of neutralizing VEGF antibodies. Blood flow and albumin permeation were increased approximately 2.5-fold 1 h after topical application of recombinant human VEGF and these effects were prevented by nitric oxide synthase (NOS) inhibitors (aminoguanidine and N(G)-monomethyl L-arginine). Topical application of a superoxide generating system increased albumin permeation and blood flow and these changes were markedly attenuated by VEGF antibody and NOS inhibitors. Application of sodium nitroprusside for 7 d or the single application of a calcium ionophore, A23187, mimicked effects of glucose, sorbitol, and VEGF on vascular dysfunction and the ionophore effect was prevented by coadministration of aminoguanidine. These observations suggest a potentially important role for VEGF in mediating vascular dysfunction induced by "hypoxia-like" cytosolic metabolic imbalances (reductive stress, increased superoxide, and nitric oxide production) linked to increased flux of glucose via the sorbitol pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Williamson, D., Lund, P., & Krebs, H. (1967) · Biochemical Journal · doi:10.1042/bj1030514 · Cited by 1,871
Shweiki, D., Neeman, M., Itin, A., & Keshet, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.768 · Cited by 599 · cited 1×
“(54) published evidence of a significant glucose induction of VEGF mRNA under normoxic conditions in a cell line derived from a rat glial tumor (Fig.”
Background
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
R�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
Byrne, A. M., Bouchier-Hayes, D. J., & Harmey, J. H. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00379.x · Cited by 744
Saint-Geniez, M., Maharaj, A. S. R., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J., & D'Amore, P. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003554 · Cited by 616
Lüscher, T. F., & Barton, M. (1997) · Clinical Cardiology · doi:10.1002/j.1932-8737.1997.tb00006.x · Cited by 536
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Self-citationPrevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide
Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E., & Williamson, J. R. (1997) · Science · doi:10.1126/science.277.5325.563 · Cited by 341
Self-citationMiyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L. P., Ogura, Y., & Adamis, A. P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65044-4 · Cited by 332
Busik, J. V., Mohr, S., & Grant, M. B. (2008) · Diabetes · doi:10.2337/db07-1520 · Cited by 312
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
Self-citationDiabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Sies, H. (2000) · Developments in Cardiovascular Medicine · doi:10.1007/978-1-4615-4649-8_1 · Cited by 260
Proinflammatory functions of vascular endothelial growth factor in alloimmunity
Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17712 · Cited by 251
Du, X., Stockklauser-Färber, K., & Rösen, P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00079-9 · Cited by 210
Flyvbjerg, A. (2000) · Diabetologia · doi:10.1007/s001250051515 · Cited by 203
The effects of oxidative stress on the development of atherosclerosis
Khosravi, M., Poursaleh, A., Ghasempour, G., Farhad, S., & Najafi, M. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0397 · Cited by 195
Paradoxes of nitric oxide in the diabetic kidney
Komers, R., & Anderson, S. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00265.2002 · Cited by 191
Howdieshell, T. R., Callaway, D., Webb, W. L., Gaines, M. D., Procter, C. D., Sathyanarayana, Pollock, J. S., Brock, T. L., & McNeil, P. L. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6089 · Cited by 188
Self-citationLong-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
Self-citationNew Insights Into Molecular Mechanisms of Diabetic Kidney Disease
Badal, S. S., & Danesh, F. R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.047 · Cited by 182
Plasma Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Diabetes
Lim, H. S., Blann, A. D., Chong, A. Y., Freestone, B., & Lip, G. Y. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2918 · Cited by 158
“By increasing substrate flux through the sorbitol pathway, elevated blood glucose can induce a hyperglycemic pseudo-hypoxic state that may induce VEGF production (22).”
BackgroundSheibani, N., Sorenson, C. M., Cornelius, L. A., & Frazier, W. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1903 · Cited by 109
ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina
Ye, X., Xu, G., Chang, Q., Fan, J., Sun, Z., Qin, Y., & Jiang, A. C. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4899 · Cited by 47
Metadata
- Authors
- Tilton, R. G., Kawamura, T., Chang, K. C., Ido, Y., Bjercke, R. J., Stephan, C. C., Brock, T. A., & Williamson, J. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-05-01
- Volume
- 99
- Issue
- 9
- Pages
- 2192-2202
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2011467776
- Cited by
- 190
- References
- 3
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.